Chitogel develops a specialized wound healing gel designed for endoscopic sinus surgery, utilizing advanced biocompatible materials to promote faster tissue regeneration. This technology addresses the challenge of prolonged healing times and complications associated with sinus surgery, enhancing patient recovery outcomes.
Funding
$6.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Endoscopic sinus surgery often results in prolonged healing times and postoperative complications, leading to patient discomfort and potentially requiring additional medical intervention. Effective wound management in the sinus cavity is challenging due to the complex anatomy and delicate tissues.
Solution
Chitogel develops a biocompatible wound-healing gel specifically designed for application following endoscopic sinus surgery. The gel is formulated to promote faster tissue regeneration and reduce the incidence of postoperative complications. By creating an optimal environment for healing, Chitogel aims to improve patient recovery and reduce the need for follow-up procedures. The specialized formulation supports the natural healing processes within the sinus cavity.
Target Audience
The primary target audience includes surgeons specializing in otolaryngology and patients undergoing endoscopic sinus surgery.
Features
- Biocompatible formulation designed for use in the sinus cavity.
- Promotes faster tissue regeneration following endoscopic sinus surgery.
- Aims to reduce postoperative complications.
- Gel format allows for easy and precise application.